Diabetes and COVID-19

Expand all | Collapse all

recent paper

  • 1.  recent paper

    Posted 10-13-2020 12:56
    Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
    Diabetes Care remove preview
    Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
    OBJECTIVE Poor outcomes have been reported in patients with type 2 diabetes and coronavirus disease 2019 (COVID-19); thus, it is mandatory to explore novel therapeutic approaches for this population.
    View this on Diabetes Care >

    we are getting a few requests from hospital medicine to use more DPP4-I -what is happening in your hospital?

    ------------------------------
    Joseph Aloi
    jaloi@wakehealth.edu
    ------------------------------


  • 2.  RE: recent paper

    Posted 10-14-2020 13:12
    Hi, we are covering hospitals in Raleigh/Cary  NC and so far were not getting those requests. Our hospitals carry linagliptin, not sitagliptin.

    ------------------------------
    Lioubov Boulkina
    CARY NC
    ------------------------------